Tagworks Pharmaceuticals
Pharmaceuticals, 235 Main St, Nijmegen, Massachusetts, 01742, United States, 11-50 Employees
Phone Number: 31 62*******
Who is TAGWORKS PHARMACEUTICALS
Tagworks Pharmaceuticals, pioneer of the Click-to-Release approach, is a precision therapy company, leveraging its technology platform, which is protected by a broad patent estate, to dev...
Read More
-
Headquarters: 235 Main St, Nijmegen, Massachusetts, 01742, United States
-
Date Founded: 2011
-
Employees: 11-50
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 5021
|
NAICS Code: 561990 |
Show More
Does something look wrong? Fix it. | View contact records from TAGWORKS PHARMACEUTICALS
Tagworks Pharmaceuticals Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Tagworks Pharmaceuticals
Answer: Tagworks Pharmaceuticals's headquarters are located at 235 Main St, Nijmegen, Massachusetts, 01742, United States
Answer: Tagworks Pharmaceuticals's phone number is 31 62*******
Answer: Tagworks Pharmaceuticals's official website is https://tagworkspharma.com
Answer: Tagworks Pharmaceuticals's revenue is Under $1 Million
Answer: Tagworks Pharmaceuticals's SIC: 5021
Answer: Tagworks Pharmaceuticals's NAICS: 561990
Answer: Tagworks Pharmaceuticals has 11-50 employees
Answer: Tagworks Pharmaceuticals is in Pharmaceuticals
Answer: Tagworks Pharmaceuticals contact info: Phone number: 31 62******* Website: https://tagworkspharma.com
Answer: Tagworks Pharmaceuticals, pioneer of the Click-to-Release approach, is a precision therapy company, leveraging its technology platform, which is protected by a broad patent estate, to develop a new standard of care for patients suffering from severe diseases including cancer. Tagworks is developing a pipeline of click-cleavable therapies. Its lead program, TGW101, is an antibody-drug conjugate (ADC) targeting TAG72, a clinically-validated, pan-carcinoma target that so far has remained out of reach of current ADC therapies. Tagworks technology enables on-target activation of ADCs and immunomodulators, as well as off-target deactivation of radioimmunotherapies to enhance their therapeutic index.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month